| PFS | OS | ||
---|---|---|---|---|
 | AHR (95% CI) | P-value | AHR (95% CI) | P-value |
NLR | ||||
 <Median | 1.05 (0.68–1.63) | 0.83 | 0.50 (0.24–1.05) | 0.07 |
 >Median | Ref |  | Ref |  |
Age | ||||
 Age > 60 | 0.75 (0.47–1.20) | 0.23 | 0.87 (0.43–1.75) | 0.69 |
 Age < 60 | Ref |  | Ref |  |
Race | ||||
 Non-White | 0.55 (0.26–1.20) | 0.13 | 0.34 (0.08–1.47) | 0.15 |
 White | Ref |  | Ref |  |
Sex | ||||
 Male | 0.95 (0.57–1.57) | 0.84 | 1.11 (0.50–2.45) | 0.79 |
 Female | Ref |  | Ref |  |
IMDC | ||||
 Poor | 2.78 (1.29–5.99) | 0.009 | 4.60 (1.15–18.32) | 0.03 |
 Intermediate | 1.42 (0.76–2.67) | 0.27 | 2.21 (0.66–7.44) | 0.20 |
 Favorable | Ref |  | Ref |  |
Prior systemic therapy | ||||
 Yes | 1.93 (1.19–3.12) | 0.008 | 0.92 (0.40–2.11) | 0.84 |
 No | Ref |  | Ref |  |